Safety Study of OPC-12759 Ophthalmic Solution
NCT01471093
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndromes
Interventions
DRUG:
OPC-12759 Ophthalmic solution
DRUG:
OPC-12759 Ophthalmic suspension
Sponsor
Otsuka Pharmaceutical Co., Ltd.